Toxoplasma ROP16(I/III) ameliorated inflammatory bowel diseases via inducing M2 phenotype of macrophages

BACKGROUND: Inflammatory bowel disease (IBD) is characterized by chronic and non-specific inflammation of the intestinal mucosa and mainly includes ulcerative colitis and Crohn's disease. AIM: To explore the beneficial effect of ToxoROP16(I/III)-induced M2 phynotype macrophages in homeostasis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yong-Wei, Xing, Rui-Xin, Zhang, Wen-Hui, Li, Lu, Wu, Yi, Hu, Jing, Wang, Cong, Luo, Qing-Li, Shen, Ji-Long, Chen, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906210/
https://www.ncbi.nlm.nih.gov/pubmed/31832003
http://dx.doi.org/10.3748/wjg.v25.i45.6634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906210/
https://www.ncbi.nlm.nih.gov/pubmed/31832003
http://dx.doi.org/10.3748/wjg.v25.i45.6634

Ejemplares similares